These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 18029144)

  • 1. o-GlcNAc transferase is activated by CaMKIV-dependent phosphorylation under potassium chloride-induced depolarization in NG-108-15 cells.
    Song M; Kim HS; Park JM; Kim SH; Kim IH; Ryu SH; Suh PG
    Cell Signal; 2008 Jan; 20(1):94-104. PubMed ID: 18029144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells.
    Goldberg H; Whiteside C; Fantus IG
    Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E713-26. PubMed ID: 21712532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium/calmodulin-dependent protein kinase type IV is a target gene of the Wnt/beta-catenin signaling pathway.
    Arrázola MS; Varela-Nallar L; Colombres M; Toledo EM; Cruzat F; Pavez L; Assar R; Aravena A; González M; Montecino M; Maass A; Martínez S; Inestrosa NC
    J Cell Physiol; 2009 Dec; 221(3):658-67. PubMed ID: 19711354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of O-linked beta-N-acetylglucosamine modification in the subcellular distribution of alpha4 phosphoprotein and Sp1 in rat lymphoma cells.
    Dauphinee SM; Ma M; Too CK
    J Cell Biochem; 2005 Oct; 96(3):579-88. PubMed ID: 16052526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase.
    Konrad RJ; Zhang F; Hale JE; Knierman MD; Becker GW; Kudlow JE
    Biochem Biophys Res Commun; 2002 Apr; 293(1):207-12. PubMed ID: 12054585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic beta cells.
    Kang ES; Han D; Park J; Kwak TK; Oh MA; Lee SA; Choi S; Park ZY; Kim Y; Lee JW
    Exp Cell Res; 2008 Jul; 314(11-12):2238-48. PubMed ID: 18570920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OGT functions as a catalytic chaperone under heat stress response: a unique defense role of OGT in hyperthermia.
    Sohn KC; Lee KY; Park JE; Do SI
    Biochem Biophys Res Commun; 2004 Sep; 322(3):1045-51. PubMed ID: 15336570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-GlcNAc modification, insulin signaling and diabetic complications.
    Issad T; Masson E; Pagesy P
    Diabetes Metab; 2010 Dec; 36(6 Pt 1):423-35. PubMed ID: 21074472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ataxin-10 interacts with O-GlcNAc transferase OGT in pancreatic beta cells.
    Andrali SS; März P; Ozcan S
    Biochem Biophys Res Commun; 2005 Nov; 337(1):149-53. PubMed ID: 16182253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress-induced expression of the p75 neurotrophin receptor is regulated by O-GlcNAcylation of the Sp1 transcription factor.
    Kommaddi RP; Dickson KM; Barker PA
    J Neurochem; 2011 Feb; 116(3):396-405. PubMed ID: 21105874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis.
    Zhang D; Cai Y; Chen M; Gao L; Shen Y; Huang Z
    Inflamm Res; 2015 Dec; 64(12):943-52. PubMed ID: 26407569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose-induced expression of MIP-1 genes requires O-GlcNAc transferase in monocytes.
    Chikanishi T; Fujiki R; Hashiba W; Sekine H; Yokoyama A; Kato S
    Biochem Biophys Res Commun; 2010 Apr; 394(4):865-70. PubMed ID: 20206135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium influx into MIN6 insulinoma cells induces expression of Egr-1 involving extracellular signal-regulated protein kinase and the transcription factors Elk-1 and CREB.
    Mayer SI; Thiel G
    Eur J Cell Biol; 2009 Jan; 88(1):19-33. PubMed ID: 18783846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalytic Promiscuity of O-GlcNAc Transferase Enables Unexpected Metabolic Engineering of Cytoplasmic Proteins with 2-Azido-2-deoxy-glucose.
    Shen DL; Liu TW; Zandberg W; Clark T; Eskandari R; Alteen MG; Tan HY; Zhu Y; Cecioni S; Vocadlo D
    ACS Chem Biol; 2017 Jan; 12(1):206-213. PubMed ID: 27935279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of calcium/calmodulin-dependent kinase IV by O-GlcNAc modification.
    Dias WB; Cheung WD; Wang Z; Hart GW
    J Biol Chem; 2009 Aug; 284(32):21327-37. PubMed ID: 19506079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into O-linked N-acetylglucosamine ([0-9]O-GlcNAc) processing and dynamics through kinetic analysis of O-GlcNAc transferase and O-GlcNAcase activity on protein substrates.
    Shen DL; Gloster TM; Yuzwa SA; Vocadlo DJ
    J Biol Chem; 2012 May; 287(19):15395-408. PubMed ID: 22311971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Streptozotocin, an analog of N-acetylglucosamine, blocks the removal of O-GlcNAc from intracellular proteins.
    Roos MD; Xie W; Su K; Clark JA; Yang X; Chin E; Paterson AJ; Kudlow JE
    Proc Assoc Am Physicians; 1998; 110(5):422-32. PubMed ID: 9756093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aβ-affected pathogenic induction of S-nitrosylation of OGT and identification of Cys-NO linkage triplet.
    Ryu IH; Lee KY; Do SI
    Biochim Biophys Acta; 2016 May; 1864(5):609-21. PubMed ID: 26854602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
    Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
    Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of topoisomerase I activity by glucose and by O-GlcNAcylation of the enzyme protein.
    Noach N; Segev Y; Levi I; Segal S; Priel E
    Glycobiology; 2007 Dec; 17(12):1357-64. PubMed ID: 17932134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.